O
SENIOR STATE ADVOCATE
obtainable from any Public Service Department or on the DPSA website link:
Closes 19 Oct 2026View role
Full Time · Co-Founding CEO (Metabolic & Inflammation Therapies) Location: Remote Commitment: Part-time to start, with greater time commitment expected as the company scales Compensation: Equity only, transitioning to salary after fundraising Start Date: ASAP preferred, Q4 2026 at the latest Seniority: Co-founder / Leadership About the CompanyThis startup is developing a new kind of small molecule to treat diabetic kidney disease (DKD) and other metabolic diseases.